Latest Market News

Iluka Resources has set the share allocation price for its 2025 Interim Dividend reinvestment plan at $6.0274, with just over 10% of shareholders opting in. The issuance of 41,852 new shares marks a cautious but steady participation in the DRP.

Beonic Ltd has raised $4.27 million through convertible notes to fund its product development, repay upcoming debt, and advance its North African Airport Project.

MetalsTech Limited’s substantial shareholders have finalized an off-market sale of 23.6 million shares, raising over $11 million and reshaping the company’s ownership landscape.

Range International has completed the first tranche of a capital raise, securing A$1.58 million to support growth in Indonesia and the Philippines while reducing debt.

1414 Degrees has returned to trading after issuing 35.7 million shares to US investor Lind Global Fund II, with approval for an additional 14.3 million shares pending at the upcoming AGM.

Liontown Resources reported a solid FY25 with A$298 million in revenue and positive EBITDA, setting the stage for a strategic underground transition in FY26 backed by a strengthened balance sheet and sustainability commitments.

Frontier Digital Ventures announces key leadership changes with Patrick Grove stepping in as Executive Chairman and a planned CEO transition by November 2025.

Sierra Nevada Gold has successfully raised A$9.65 million through a share placement to accelerate exploration in Nevada and Saudi Arabia, while appointing former De Grey Mining chairman Simon Lill as its new Non-Executive Chairman.

Nickel Industries has successfully issued US$800 million in senior unsecured notes at a 9% coupon, extending its debt maturity to 2030 and reducing annual amortisation by US$88 million. The company also launched a tender offer to repurchase higher-cost notes maturing in 2028.

Lord Resources has raised $814,000 through a strongly supported placement and is launching a $1.6 million entitlement issue to accelerate exploration at its Ilgarari Copper Project in Western Australia.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

TasFoods has agreed to sell its Pyengana Dairy business for $2 million, aiming to reduce debt and refocus on its poultry supply chain. The sale awaits shareholder approval with settlement expected by early November.